Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Phase I study of Pazopanib (PAZ) in Hepatocellular Carcinoma (HCC): evaluation of clinical activity, Pharmacokinetics (PK), and Dynamic Contrast Enhanced MRI (DCE-MRI) Proceeding/Conference:European Journal of Cancer Supplements | 2009 |